Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:158
作者
Hogendoorn, P. C. W. [1 ,2 ]
Athanasou, N. [2 ]
Bielack, S. [3 ]
De Alava, E.
Tos, A. P. Dei [4 ]
Ferrari, S. [5 ]
Gelderblom, H.
Grimer, R. [6 ]
Hall, K. Sundby [7 ]
Hassan, B. [8 ]
Hogendoorn, P. C. W. [1 ,2 ]
Jurgens, H. [9 ]
Paulussen, M. [10 ]
Rozeman, L.
Taminiau, A. H. M.
Whelan, J. [11 ]
Vanel, D. [5 ]
机构
[1] Univ Med Ctr, Dept Pathol, Leiden, Netherlands
[2] Univ Oxford, Oxford, England
[3] Olga Hosp, Stuttgart, Germany
[4] Osped Civile, Treviso, Italy
[5] Ist Ortoped Rizzoli, Bologna, Italy
[6] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England
[7] Norwegian Radium Hosp, Oslo, Norway
[8] Weatherall Inst Mol Med, Oxford, England
[9] Univ Klinikum, Munster, Germany
[10] Univ Childrens Hosp Basel, Basel, Switzerland
[11] Univ Coll London Hosp, London, England
关键词
NONMETASTATIC EWINGS-SARCOMA; CORE NEEDLE-BIOPSY; PROGNOSTIC-FACTORS; DEDIFFERENTIATED CHONDROSARCOMA; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; ONCOLOGY-GROUP; YOUNG-ADULTS; LONG BONES;
D O I
10.1093/annonc/mdq223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:v204 / v213
页数:10
相关论文
共 78 条
[1]   Recommendations for the reporting of bone tumors [J].
Abdul-Karim, FW ;
Bauer, TW ;
Kilpatrick, SE ;
Raymond, KA ;
Siegal, GP .
HUMAN PATHOLOGY, 2004, 35 (10) :1173-1178
[2]   Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours [J].
Altuntas, AO ;
Slavin, J ;
Smith, PJ ;
Schlict, SM ;
Powell, GJ ;
Ngan, S ;
Toner, G ;
Choong, PFM .
ANZ JOURNAL OF SURGERY, 2005, 75 (04) :187-191
[3]   Medical Progress - Common musculoskeletal tumors of childhood and adolescence [J].
Arndt, CAS ;
Crist, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :342-352
[4]   TRANSLOCATION INVOLVING CHROMOSOME-22 IN EWINGS-SARCOMA - A CYTOGENETIC STUDY OF 4 FRESH TUMORS [J].
AURIAS, A ;
RIMBAUT, C ;
BUFFE, D ;
ZUCKER, JM ;
MAZABRAUD, A .
CANCER GENETICS AND CYTOGENETICS, 1984, 12 (01) :21-25
[5]   Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Rimondini, S ;
Longhi, A ;
Bacchini, P ;
Forni, C ;
Manfrini, M ;
Donati, D ;
Picci, P .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :4-11
[6]   Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992 [J].
Bacci, G ;
Forni, C ;
Longhi, A ;
Ferrari, S ;
Donati, D ;
De Paolis, M ;
Barbieri, E ;
Pignotti, E ;
Rosito, P ;
Versari, M .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (01) :73-83
[7]   Utilization of positron emission tomography in the management of patients with sarcoma [J].
Benz, Matthias R. ;
Tchekmedyian, Nishan ;
Eilber, Fritz C. ;
Federman, Noah ;
Czernin, Johannes ;
Tap, William D. .
CURRENT OPINION IN ONCOLOGY, 2009, 21 (04) :345-351
[8]   Ewing's sarcoma family of tumors: Current management [J].
Bernstein, Mark ;
Kovar, Heinrich ;
Paulussen, Michael ;
Randall, R. Lor ;
Schuck, Andreas ;
Teot, Lisa A. ;
Juergens, Herbert .
ONCOLOGIST, 2006, 11 (05) :503-519
[9]   Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric oncology group/children's cancer group phase II study 9457 - A report from the children's oncology group [J].
Bernstein, ML ;
Devidas, M ;
Lafreniere, D ;
Souid, AK ;
Meyers, PA ;
Gebhardt, M ;
Stine, K ;
Nicholas, R ;
Perlman, EJ ;
Dubowy, R ;
Wainer, IW ;
Dickman, PS ;
Link, MP ;
Goorin, A ;
Grier, HE .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :152-159
[10]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790